Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
13 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Savara Inc.’s names, not what it holds today.
Patents granted
13
13 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
21
1 of them in 2025
Names they are printed under
5
a former name, its own name
By yearGrantedApplications published
'07'08'11'12'13'14'15'16'17'19'20'21'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name5 counted
Adventrx Pharmaceuticals a former name
US, as the owner printed on each patent
7 publishedMast Therapeutics, Inc. a former name
US, as the owner printed on each patent
3 publishedSAVARA INC. its own name
named as the applicant on its applications, in US
6 publishedSavara Inc. its own name
US, as the owner printed on each patent
1 publishedMast Therapeutics, Inc. a former name
named as the applicant on its applications, in US
4 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Feb 18, 2020 | 10,561,608 | Dry powder Vancomycin compositions and associated methods | Pharmaceuticals | Savara Inc. |
| Nov 12, 2019 | 10,471,083 | Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | Pharmaceuticals | Savara Inc. |
| Sep 24, 2019 | 10,420,722 | Dry powder vancomycin compositions and associated methods | Pharmaceuticals | Savara Inc. |
| Sep 10, 2019 | 10,406,171 | Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties | Pharmaceuticals | Savara Inc. |
| Feb 21, 2017 | 9,572,774 | Dry powder vancomycin compositions and associated methods | Pharmaceuticals | Savara Inc. |
| Aug 2, 2016 | 9,403,941 | Poloxamer composition free of long circulating material and methods for production and uses thereof | Pharmaceuticals | Mast Therapeutics, Inc. |
| Oct 15, 2013 | 8,557,861 | Low oil emulsion compositions for delivering taxoids and other insoluble drugs | Pharmaceuticals | Mast Therapeutics, Inc. |
| Jun 25, 2013 | 8,470,873 | Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof | Pharmaceuticals | Mast Therapeutics, Inc. |
| Jun 25, 2013 | 8,470,346 | Anti-viral pharmaceutical compositions | Pharmaceuticals | Mast Therapeutics, Inc. |
| Jul 17, 2012 | 8,222,268 | Methods for reducing vein irritation | Pharmaceuticals | Adventrx Pharmaceuticals |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Feb 27, 2025 | 2025/0064893 | METHODS FOR THE TREATMENT OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS | Pharmaceuticals | SAVARA INC. |
| May 27, 2021 | 2021/0154137 | DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS | Pharmaceuticals | SAVARA INC. |
| May 21, 2020 | 2020/0155451 | DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS | Pharmaceuticals | SAVARA INC. |
| Apr 16, 2020 | 2020/0115412 | SEPARATION OF VANCOMYCIN AND ITS DEGRADATION PRODUCTS | Chemical engineering | SAVARA INC. |
| Dec 19, 2019 | 2019/0380955 | DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS | Pharmaceuticals | SAVARA INC. · patent 10,561,608 granted from it |
| Mar 14, 2019 | 2019/0076466 | REDUCED SODIUM POLOXAMER-188 FORMULATIONS AND METHODS FOR USE | Pharmaceuticals | Mast Therapeutics, Inc. |
| Jan 5, 2017 | 2017/0002141 | POLOXAMER COMPOSITION FREE OF LONG CIRCULATING MATERIAL AND METHODS FOR PRODUCTION AND USES THEREOF | Pharmaceuticals | Mast Therapeutics, Inc. · patent 10,501,577 granted from it |
| Aug 18, 2016 | 2016/0235781 | DIURETIC INDUCED ALTERATIONS OF PLASMA VOLUME | Pharmaceuticals | Mast Therapeutics, Inc. |
| Mar 31, 2016 | 2016/0089330 | DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS | Pharmaceuticals | SAVARA INC. · patent 10,420,722 granted from it |
| Jan 7, 2016 | 2016/0002401 | POLOXAMER COMPOSITION FREE OF LONG CIRCULATING MATERIAL AND METHODS FOR PRODUCTION AND USES THEREOF | Pharmaceuticals | Mast Therapeutics, Inc. · patent 9,403,941 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.